glp-1 agonists for type 2 diabetes New Developments in Pharmacological Treatment of Obesity and Diabetes—Beyond and within Receptor Glucagon-Like Peptide 1 Receptor Agonists
Description
When prescribing is supervised and thoughtful, these medicines are effective and safe. Louwagie agrees that the case report highlights the need for individualized care
Thus, our department has been a pioneer in utilizing these drugs since the early evidence demonstrated their efficacy
Pharmacokinetics, safety, and tolerability of oral semaglutide in subjects with hepatic impairment
Rossing et al
2005 doi: 10.1111/j.1365-2249.2005.02934.x
Your genetic background, cardiovascular health, and metabolic profile may influence which approach your provider recommends
